Last updated on April 18, 2014 at 17:24 EDT

Latest Cochrane Group Stories

2011-01-12 14:44:05

Tom Jefferson and colleagues from the Cochrane Group argue that the current system for assessing the safety and effectiveness of drugs, based on published trial data only, is "wholly inadequate" and "ethically dubious." They propose a new approach that would allow in-depth scrutiny of the complete set of trial data for a new drug. Their call comes after they reviewed the evidence for the antiviral drug oseltamivir (Tamiflu), and were unable to find sufficient published data to support the...